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ABSTRACT
Background: Prostate cancer is the most common cancer among men, and the incidence
is 1.65 times higher in African Americans than Caucasians. The newly discovered PIWI/piRNA
pathway, which regulates transposon and gene expression via small non-coding RNAs, has been
implicated in certain aspects of cancer etiology. We hypothesize a novel involvement of the
pathway via aberrant gene regulation due to sequence variants within piRNAs and test this
hypothesis in relation to prostate cancer in both an African American and Caucasian sample.
Methods: To interrogate SNPs embedded in piRNA sequences, we utilized genome-wide
genotype data to impute 1,000 Genomes SNPs falling within piRNAs. We then tested for
associations at these variants in bothe populations, while controlling for appropriate covariates
and principal components. The regions encompassing significant SNPs were subsequently fine
mapped. Results: In the African American sample one variant falling within a piRNA,
rs61101785, was significantly associated with prostate cancer (FDR-p < 0.10). Fine mapping
showed this variant to be the peak of an association signal. The variant is absent in the Caucasian
sample. Conclusions: We have tested a novel hypothesis for the involvement of PIWI/piRNAs
in cancer risk in a cancer estimated to make up 25% of new male cancer cases in 2015. Our
results show the potential for a variant within a piRNA to affect cancer risk. Additionally, the
risk variant is absent in Caucasians, potentially explaining some of the racial differences in
prostate cancer risk.
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INTRODUCTION
Prostate cancer is the most common cancer in men, with men facing a 15% lifetime risk
of developing the cancer and it predicted to make up 26% of new cancer cases in males in 2015,
for a total of 220,800 new cases1. Additionally, it is predicted to account for 9% of cancer related
deaths in men during 20151. During the period of 2007-2011, the incidence of prostate cancer
was about 1.65 times higher in African Americans than in Caucasians1. Additionally, recent
research demonstrated that race modifies the risk of prostate cancer due to obesity, with obesity
being a stronger risk factor in African Americans than Caucasians2. Among other factors, it has
been hypothesized that the difference in prostate cancer risk between these two races has a
genetic component3. By performing this study in both an African American and Caucasian
sample, we may be able to shed light on genetic contributions to these racial differences.
The discovery of PIWI proteins and PIWI-interacting RNA (piRNAs), a class of small
non-coding RNAs, and the subsequent understanding of their biological role has spawned
interest in the potential role of these small RNAs in disease. The piwi gene was first identified in
drosophila through a genetic screen for genes affecting asymmetric division of germline stem
cells4,5, and was then found to code for a highly conserved protein present in the stem and
somatic cells of the drosophila germline that is implicated in germline establishment and
maintenance4-6. PIWI proteins are members of the Argonaute family of proteins, which contain a
PAZ domain that binds single-stranded RNA, a MID domain, and a PIWI domain that resembles
the endonuclease RNase-H7. Homologs of drosophila piwi were then identified in various other
organisms including mice and humans8-10. After the discovery of PIWIs, it was shown that the
already characterized rasiRNAs and additional small RNAs interact with PIWI proteins, thus
being named piRNA11-15. The piRNAs identified primarily mapped to intergenic regions and are
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enriched in repetitive elements, with about 20% in vertebrates mapping to transposon
sequences11-13.
Work to determine the function of PIWI/piRNAs has shown that the two are involved in
the repression of transposable elements through transcriptional and post-transcriptional
mechanisms, likely to maintain genome integrity15-24. In terms of transcriptional regulation, it has
been shown that mutations in drosophila piwi and aub, two PIWIs, lead to a failure to establish
H3K9me2/3 marks, a repressive histone modification25-27. In drosophila, this mechanism
involves the interaction of PIWI proteins with Heterochromatin Protein-1 (HP1), demonstrating
the ability of PIWI/piRNA complexes to recruit epigenetic modifiers to gene loci28,29. The
processes of inducing epigenetic changes involves PIWI-bound piRNAs guiding PIWI in
complex with epigenetic regulators to complementary DNA sequences or nascent transcripts
where their action can take place30.
Being of the same gene family as the proteins known to interact with miRNA, it is not
surprising that evidence of a gene regulatory role for PIWI/piRNAs has also arisen. There is
evidence in mice of PIWI/piRNAs directing the methylation of promoters, a DNA modification
associated with decreased gene expression, in a sequence specific manner31. In drosophila,
cytoplasmic PIWIs participate in inhibiting maternal mRNA translation and maternal mRNA
decay via CCR4 mediated deadenylation by complementarity with their 3’ UTRs32. Further,
piRNAs can be generated from the 3’ UTR of certain mRNAs in Drosophila, Xenopus, and mice,
providing another possible method of regulation33.
As these functions of PIWI proteins and piRNA have been elucidated, evidence of their
association with cancers has come to light. PIWI expression has been demonstrated in a variety
of human cancers, including colorectal, hepatic, brain, pancreatic, testicular, prostate, breast,
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gastrointestinal, ovarian, and endometrial cancers34-40. Additionally, expression of piRNAs has
been observed in cancer cell lines and tissue samples41-43. Of these, specific piRNAs have been
observed to be under- or over-expressed in tumor tissue as compared to adjacent normal tissue,
and amelioration of this aberrant expression showed the effect of decreasing cell
proliferation42,43.
Herein, we propose a potential novel involvement of the PIWI/piRNA pathway in
tumorigenesis. Specifically, we hypothesize that sequence variants within piRNAs may play a
role in cancer risk by aberrant regulation of tumor suppressor or oncogene expression. As
piRNAs serve as a sequence specific guide for PIWI proteins, their action at certain loci may be
abolished or aberrantly target novel loci. This idea is supported by the fact that single nucleotide
changes in piRNAs can lead to a substantial loss of efficiency at intended target sites30. Here, we
test this hypothesis in relation to prostate cancer in an African American population derived from
the Multi-ethnic Cohort (MEC) and Caucasian population from the Cancer Genetic Markers of
Susceptibility (CGEMS) Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
(PLCO) by investigating associations with single nucleotide polymorphisms (SNPs) embedded
in piRNA sequences. We have limited our analyses to piRNAs derived from 100 or fewer
genetic loci, as there is evidence that low copy number piRNAs are more likely to regulate
protein-coding gene expression44

METHODS
Data
Data for this study were obtained from the Database of Genotypes and Phenotypes
(dbGaP) and includes genotype and phenotype data for African American subjects from the
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GENEVA Prostate Cancer study (phs000306.v4.p1) genotyped on the Illumina Human1MDuov3_B platform and Caucasian subjects from the CGEMS PLCO Prostate Cancer study
(phs000207.v1.p1) genotyped on the Illumina HumanHap300v1.1 and HumanHap250Sv1.0
platforms. The subjects in the GENEVA study were derived from the MEC45, as well as six
additional studies as documented by Freedman et al.46,47. Subjects in the PLCO study were
drawn from the PLCO Cohort by an incidence density sampling method48.
Data Cleaning
All data cleaning/management was performed using PLINKv1.0749. For both study
populations, consent groups were all genotyped on the same platform and were merged to make
a complete data set. However, prior to merging consent groups the data were cleaned to remove
individuals with a call rate <90%, SNPs with a call rate <95%, and SNPs not following HWE
(p<0.0001). SNPs of low MAF were not removed, as they were not to be used for association
analyses and would help inform subsequent imputation. SNPs on the Y chromosome, from
pseudo-autosomal regions, and mitochondrial SNPs were removed. The data was then lifted over
to genome build 37, and variant coding was flipped as necessary to be on the (+) genomic strand
in order to be compatible with the imputation reference panel. One sample was removed from
each related or duplicate pair in the data, as determined by πˆ ≥ 0.2 from IBS analysis in plink49.
Individuals not self-declared for the ancestry of interest were also excluded. Ancestry checks
€
were then performed by combining the genome-wide data with a HapMap reference panel

followed by principal component analysis using EIGENSTRAT50. All subjects in the Caucasian
population clustered well with HapMap Caucasians, so no removals were made. However, due to
African Americans being an admixed population and no clear clustering in relation to HapMap
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samples, PCA was performed using EIGENSTRAT50 and subjects exceeding six standard
deviations on any of the top ten principal components were removed with one iteration.
piRNA SNP Genotype Imputation
We utilized piRNA Bank51 to determine the position, sequence, and copy number of all
curated human piRNA sequences. This includes 32,149 unique piRNAs that map to 667,944
genomic loci. We then used the 1,000 Genomes Phase 3 reference data available for IMPUTE252
and piRNA coordinates to determine all SNPs mapping to genomic coordinates covered by
piRNAs encoded at 100 or fewer loci, as imputation is limited to variants in the reference panel.
Next, imputation was carried out using IMPUTE2 in 5 MB segments with the programs default
settings52. The program outputs a probability of having each of the three possible genotypes for
each individual. SNPTEST then uses these probabilities to determine allele dosages for use in a
logistic regression model as described in the subsequent section.
Association Analyses
Association analyses were carried out in SNPTESTv2.5 using unconditional logistic
regression with an additive allelic model that inputs posterior genotype probabilities as dosages
and accounts for uncertainty due to imputation53. Prior to the analyses, monomorphic SNPs as
well as those with MAF<1% or with an info score <0.9 from IMPUTE2 were excluded. For the
analyses in African Americans, models were adjusted for 3 principal components, an ordinal
variable representing age categories, and study. The analyses in Caucasians controlled for 3
principal components, an ordinal age category variable, and family history of prostate cancer.
For both analyses age was grouped by ten-year increments, and the number of principal
components to control for was determined by calculating a genomic inflation factor (GIF) and
inspecting QQ plots both generated using genome-wide data. Principal component analysis was
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carried out in EIGENSTRAT50 with LD-pruned data generated from plink49 using a pairwise R2
threshold of 0.5.
Fine Mapping
Fine mapping was performed on regions containing variants associated with prostate
cancer. For this, all variants from the Thousand Genomes reference panel in the original 5MB
imputation window of the associated SNP were imputed using IMPUTE2 in the same manner as
previously. Association testing was then carried out using SNPTEST for all variants in a 500KB
window centered on the SNP of interest while controlling for all of the same variables as in the
piRNA variant association analyses. Imputed variants were limited based on an info quality
metric of 0.6. P-values were then used to generate Manhattan plots for inspection of the
distribution of the association signal.

RESULTS
GENEVA Study
After data cleaning in preparation for piRNA variant imputation, the African American
population consisted of 2,275 cases and 2,425 controls for a total of 4,700 individuals with
genotype data at 1,121,335 SNPs. During cleaning, 48 individuals were removed following IBS
analysis (Figure S1a) and 22 were removed due to being PCA outliers after it was determined
this would be necessary by inspection of ancestry plots (Figure S2a). Following this, piRNA
SNP genotypes were imputed for each subject at all possible piRNA variants using IMPUTE252.
Prior to association testing, variants that were monomorphic, had a MAF<1%, or an IMPUTE2
quality info score < 0.9 were removed. The association analyses were controlled for the study a
subject was drawn from, age categorized in ten year increments, and the top three eigenvectors
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from PCA. The choice to control for three principal components was made based on the
observation of a GIF of 1.00 from genome-wide association analyses and examination of QQ
plots generated from these analyses (Figure S3a).
Association analyses, controlled as described above, were carried out for 1847 variants,
the results of which are displayed in Figure 1. The variant rs61101785, located in piR-021163,
was associated with an increased risk of prostate cancer [FDR-p=0.070], with an odds ratio of
1.63 [95% CI: 1.29-2.05] (Table 1). The MAF of the variant was 4.1% in cases and 2.6% in
controls, and is located at Chr4: 3,074,158. The piRNA it falls within maps only to this locus51.
The locus lies within the first intron of the Huntingtin antisense 1 (HTT-AS1) transcript (UCSC
Genome Browser). Fine mapping of the region encompassing rs61101785 revealed that the
association signal peaks at that variant falling within piR-021163 (Figure 2).
PLCO Study
After data cleaning, there were 1,142 cases and 1,098 controls for a total of 2,240
Caucasian subjects from the PLCO study genotyped at 541,721 variants. During cleaning, 7
samples were removed due to not being genotyped on both platforms and 53 were removed
following IBS analysis (Figure S1b). All remaining subjects clustered well with HapMap
Caucasians on the top two principal components (Figure S2b), so no PCA outlier removal was
performed. Next, all SNPs falling within piRNAs encoded at 100 or fewer loci were imputed for
use in association analyses. The association tests were adjusted for family history of prostate
cancer, age categorized in ten year increments, and the top three principal components from PCA
based on a GIF of 1.00 and QQ plot inspection (Figure S3b). As in the African American
population, variants that were monomorphic, had a MAF<1%, or an IMPUTE2 info score < 0.9
were removed. Associations were tested at 1,364 SNPs, the results of which are summarized in
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Figure 3. The top three hits are all located within the same piRNA cluster on Chromosome 1451,
which lies in an intergenic region. Interestingly, the hits within this single piRNA cluster all
correspond to single copy piRNAs. The fine mapping carried out on the imputation region
encompassing rs8010969 and rs11625907 revealed that they are likely tagging a causal SNP
(Figure 4).

DISCUSSION
Here, we have performed the first comprehensive analysis investigating the association
between genetic variants within piRNAs and prostate cancer in both an African American and
Caucasian sample. The study focused on an African American sample genotyped as part of the
GENEVA study and Caucasian population drawn from the PLCO study, both available via
dbGaP. Investigation of associations between imputed piRNA variants and prostate cancer
revealed a highly interesting association in the African American study sample. A variant falling
within the singly encoded piR-021163, rs61101785, was associated with an increased risk of
prostate cancer in African Americans (FDR-p=0.0702). Fine mapping of the region
encompassing rs61101785 demonstrated that the association signal peaks at the variant. This
supports the idea of a functional role for this variant given the signal is real. The location of the
variant (Chr4: 3,074,158) and piRNA (Chr4: 3,074,147-3,074,178) falls within the first intron of
the HTT-AS1 transcript. HTT-AS1 is non-coding and antisense to the Huntingtin (HTT) gene54,
a gene causally linked to Huntington’s disease when containing a PolyQ expansion55,56, with the
two being transcribed head-to-head. The HTT-AS1 transcript is known to regulate the expression
of the HTT gene in a partially Dicer dependent manner54. The normal HTT gene has been
implicated in cell survival57, an important aspect of cancer development and progression.
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Interestingly, piRNAs typically target transposons by deriving from antisense transcripts and
imprinting of the Rasgfr1 locus in mice involves the targeting of an adjacent antisense transcript
by a specific piRNA31. Although speculative, it is possible that this piRNA is derived from the
antisense transcript and can then target the genomic locus. Another interesting aspect of this
variant is that it was virtually monomorphic in the Caucasian sample, with only two cases being
heterozygous at this position. This could partially account for the race differences observed in
prostate cancer risk.
The associations observed in the piRNA cluster on chromosome 14 in the Caucasian
sample are all likely reflecting the same functional variant if one is truly present. Future work
may investigate if any of these piRNA variants differentially affect aspects of cancer
development and progression as compared to the wildtype piRNAs.
A strength of this study is the Thousand Genomes reference panel used for imputation, as
this data has highly comprehensive coverage of an immense number of variants. This allowed us
to achieve coverage of many piRNA embedded SNPs. Howevever, we could not interrogate
variants within piRNAs not included in the reference panel, which means some piRNAs were not
interrogated. Another drawback is the fact that we cannot conclude that these variants are causal,
as they may be tagging variants in linkage-disequilibrium with them. However, future functional
analyses will help understand whether or not these variants are playing a role in cancer risk.
Future work will focus on the effects of the wildtype and variant piRNA-021163 on aspects of
tumorigenesis, including proliferation. Also, work may focus on the gene regulatory effects of
the piRNA, which can be difficult to predict. Finally, we were limited to covariates provided in
the dbGaP datasets, and could have potentially further controlled for confounding factors to
bolster our results.
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Overall, we provide the first evidence that piRNA sequence variants could potentially be
associated with prostate cancer, with a strong finding coming from our African American sample
that could in part explain racial differences in prostate cancer risk. Fine mapping of the region
strengthened this idea, and future functional work will help to understand how this variant may
be affecting risk. Therefore, it is possible that not only abberant expression of PIWIs or piRNAs
can play a role in cancer but piRNA sequence changes may also be a factor.
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TABLES & FIGURES

rs61101785

Figure 1: A Manhattan plot displaying the association results for imputed piRNA variants from
the African American subjects of the GENEVA study. The significantly associated variant,
rs61101785, is highlighted in green.
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piRNA

MAF
Cases

14!
MAF
Controls

OR
[95% CI]

P

FDRAdjusted
P

3.80E-05

0.070

3.89E-04

0.359

3.55E-03

0.596

GENEVA (n=4,700)
rs61101785
rs62439721
rs11074184

Chr4:
3,074,158
Chr7:
6,762,443
Chr15:
93,970,292

piR-021163

4.1%

2.6%

piR-003123

16.8%

19.3%

piR-008061

9.6%

11.6%

1.63
[1.29, 2.05]
0.84
[0.76, 0.94]
0.81
[0.71, 0.93]

PLCO (n=2,240)
Chr14:
piR-013783
1.28
rs8010969
19.6%
16.0%
1.18E-03
88,626,243 piR-014246
[1.10, 1.49]
Chr14:
1.28
rs11625907
piR-008286 19.7%
16.0%
1.17E-03
88,625,605
[1.10, 1.49]
Chr14:
1.28
rs8020378
piR-018495 19.7%
16.0%
1.15E-03
88,624,946
[1.10, 1.50]
Table 1: Summary of the top three hits from the GENEVA African American and PLCO

0.180
0.199
0.225

Caucasian samples. FDR-adjusted p-values < 0.10 and < 0.20 were considered significant and
suggestive, respectively.
rs61101785

Figure 2: A Manhattan plot displaying the results of fine mapping of the region encompassing
rs61101785, which is highlighted in green.
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rs8010969
rs11625907

Figure 3: A Manhattan plot displaying the association results for imputed piRNA variants from
the Caucasian subjects of the PLCO study. The variants rs8010969 and rs11625907 are
highlighted in green.
rs8010969
rs11625907

Figure 4: A Manhattan plot displaying the results of fine mapping of the region encompassing
the variants rs8010969 and rs11625907, which are highlighted in green.
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SUPPLEMENTS

Figures S1a and S1b: IBS analysis. Plots of the probability of sharing one allele at a given locus
vs. the probability of sharing zero alleles at a given locus. One sample was removed from each
pair in red.
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Figures S2a and S2b: Plots of the first two principle components from PCA analysis of study
subjects merged with HapMap references. CEU = Caucasian, JPT/CHB = East Asian, YRI =
Yoruba (West Africa).
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Figure S3a and S3b: QQ plots based on genome-wide associations adjusted for the covariates
used in the association analyses for both studies.
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